Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag is a postdoctoral researcher in psychology with a Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences. His research bridges schizophrenia, brain imaging, and educational psychology. Dr. Uludag is passionate about disseminating scientific knowledge through his personal website (ifx0.com/psychology), YouTube channel (youtube.com/boooringlearning), and as the founder of the open-access journal Novelty in Psychology. He has published extensively, including 12 Web of Science (Q1) and 21 Scopus-indexed works, and serves on the editorial boards of 24 international journals. With over 670 manuscript reviews listed on ORCID, he has received multiple awards recognizing his scientific contributions. Dr. Uludag also manages four ongoing book projects. Skilled in Python-based machine learning and data analysis tools, he is eager to collaborate on innovative research that contributes meaningfully to psychology and society.

Profile

Education 🎓

Dr. Uludag earned his Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences (2019–2023, GPA 3.93), focusing on brain imaging and mental health. He completed an M.A. in Forensic Sciences (Social Sciences) from Istanbul University (2016–2018, GPA 3.61), where he developed a strong foundation in psychological evaluation in legal settings. His undergraduate degree in Psychological Counseling and Guidance was obtained from Çanakkale Onsekiz Mart University (2012–2016, GPA 3.30), complemented by an associate degree in Laboratory Assistant and Veterinary Sciences from Eskisehir Anatolian University (2013–2015, GPA 3.79). He has also pursued training in TESOL, SPSS, machine learning (random forest, SVM, logistic regression, neural networks), Python programming, web development, and data visualization. His education has been guided by distinguished scholars including Prof. Xiang Yang Zhang, Prof. Erdinc Ozturk, and Prof. Neylan Ziyal. These experiences shaped his multidisciplinary approach to psychological research.

Experience 👨‍🏫

Dr. Kadir Uludag is currently a postdoctoral researcher at Shanghai Jiao Tong University (2023–Present) and has been appointed for a future role at Capital Medical University, Beijing (2025–). His expertise spans schizophrenia, neuroimaging, and educational psychology. Previously, he served as a special education teacher for autistic children at Karabük Municipality Autistic Children Education Center (2017), applying cognitive-behavioral and humanistic therapeutic approaches. He also completed internships as a psychological counselor at Toki Anadolu Lisesi (2016) and a veterinary technician at Safranbolu Veterinary Clinic (2015). He brings in-depth knowledge of psychological development and intervention techniques across diverse settings. In academia, Dr. Uludag serves on the editorial boards of 24 journals and has edited four book projects. His dynamic involvement in teaching, research, editing, and mentoring reflects a holistic commitment to the field of psychology and science communication.

Awards & Recognitions 🏅

Dr. Uludag has received numerous accolades, including the “Highest Number of Views” award (2023–2024) from the Journal of Clinical and Basic Psychosomatics for his narrative review on smoking and schizophrenia. He earned reviewer awards from Imeta Journal and Imetaomics for reviewing more than five papers each. Additionally, he holds a Certificate of Excellence from the Shanghai Table Tennis Museum and the American Chemical Society Reviewer Lab Certificate. His extensive peer-review contributions (over 670 reviews) are recognized by ORCID and editorial teams worldwide. His editorial involvement includes serving on boards of journals like Health Policy and Technology, Plos One, and Asean Journal of Psychiatry, among others. He has received invitations for guest editorships and honorary memberships in various scholarly outlets. These honors reflect his impactful presence in academia and his dedication to advancing global psychological research.

Research Interests 🔬

Dr. Kadir Uludag’s primary research interests include schizophrenia, neuroimaging (fMRI and EEG), and educational psychology. His doctoral work applied Python-based machine learning (random forest, SVM, logistic regression) to brain imaging data, emphasizing computational psychiatry and precision diagnostics. He has published in Q1 journals such as Asian Journal of Psychiatry, American Chemical Neuroscience, Psychology Research and Behavior Management, General Psychiatry, and Antioxidants. His Scopus-indexed contributions span educational psychology, forensic science, and neuroscience. His research applies interdisciplinary tools—Python, Psychopy, SPSS, R, NLP, and image processing libraries—to explore psychiatric conditions. He integrates theory and practice through data visualization, cognitive-behavioral therapy models, and open-science advocacy. Dr. Uludag actively shares findings via his YouTube channel and academic website, fostering transparency and education. His work aims to bridge gaps between neuroscience, education, and technology to improve mental health outcomes and knowledge dissemination.

Publications

Korchia Theo | Psychiatry | Best Researcher Award

Dr. Korchia Theo | Psychiatry | Best Researcher Award

Dr. Théo Korchia 🇫🇷 is a French psychiatrist specializing in early-onset schizophrenia 🧩, with a passion for innovation in mental health care 💡. Based at Aix-Marseille University and APHM 🏥, he completed a research fellowship at McGill University in Montreal 🇨🇦. His groundbreaking work emphasizes personalizing antipsychotic treatment using pharmacogenetics 🧬, improving patient adherence and quality of life ❤️. His notable contributions include addressing sexual dysfunction in schizophrenia treatment 💔, a topic often neglected. He published a major meta-analysis in JAMA Psychiatry 📘, shedding light on its prevalence. Winner of the Schizophrenia International Research Society award 🏆, Dr. Korchia advocates for a psychiatry that is humane, patient-centered, and scientifically rigorous 🔬. His work not only enhances clinical outcomes but also builds stronger therapeutic alliances through trust and transparency 🤝. Driven by compassion and innovation, he envisions a future where mental health care is personalized, inclusive, and profoundly impactful 🌍.

Profile

Education 🎓

Théo Korchia began his medical education in France 🎓, obtaining his degree in psychiatry with a focus on early-onset psychotic disorders 🧠. Supported by Aix-Marseille University and APHM 🏥, his academic journey was enriched by international exposure at McGill University 🇨🇦, where he deepened his expertise in psychiatric research and pharmacogenetics 🧬. His commitment to academic excellence led to extensive training in clinical practice, psychopharmacology, and patient-centered care 🩺. Throughout his studies, he explored the intersection of pharmacology, genetics, and psychiatry, aiming to personalize schizophrenia treatment for better efficacy and fewer side effects 🧪. His education was marked by a strong emphasis on translational research, ethics, and therapeutic alliance 🤝. Dr. Korchia continues to be involved in academic teaching and mentoring, sharing his knowledge with students and young professionals 📚. His education forms the bedrock of his mission: to evolve psychiatric care into a more compassionate, evidence-based, and individualized discipline 🌟.

Experience 👨‍🏫

Dr. Korchia’s clinical journey began in France 🇫🇷 at APHM and Aix-Marseille University 🏥, where he treated patients with early-onset schizophrenia and related psychotic disorders 🧠. His international experience includes a transformative year of research at McGill University 🇨🇦, focusing on pharmacogenetics and treatment personalization 🧬. In both hospital and research settings, he has contributed to improving psychiatric care through innovative approaches, especially regarding the management of antipsychotic side effects 🩻. With a hands-on approach, he integrates patient voices in treatment plans 🗣️, fostering therapeutic alliance and adherence 🤝. He has collaborated with multidisciplinary teams, presented findings at international conferences 🌐, and published in high-impact journals like JAMA Psychiatry 📘. Passionate about breaking stigmas, Dr. Korchia also advocates for the recognition of sexual dysfunction in psychiatric care 💔. His experience bridges cutting-edge science and compassionate care, making him a leading voice in progressive psychiatry 💡.

Awards & Recognitions 🏅

Dr. Théo Korchia was honored by the Schizophrenia International Research Society 🏆 for his pioneering research in early-onset schizophrenia treatment 🧠. He was supported by Aix-Marseille University and the Assistance Publique des Hôpitaux de Marseille 🎓🏥, which facilitated his international research fellowship at McGill University 🇨🇦. His impactful publication in JAMA Psychiatry 📘—a meta-analysis involving 21,000+ patients—highlighted sexual dysfunction prevalence in schizophrenia, earning him global recognition 🌍. His work addressing often-ignored dimensions of psychiatric care, such as sexual health 💔, has been lauded for its clinical relevance and humanistic perspective. Known for combining scientific rigor 🔬 with empathy ❤️, he is frequently invited to share insights at conferences and symposiums worldwide 🎤. These accolades reflect not only academic excellence but also his commitment to enhancing patient-centered care 🧩. Dr. Korchia’s recognition symbolizes a growing awareness of the holistic needs of individuals with mental illness 🌟.

Research Interests 🔬

Dr. Korchia’s research centers on early-onset schizophrenia 🧠, with a sharp focus on pharmacogenetics 🧬 to personalize antipsychotic treatments and minimize side effects. He addresses the often-overlooked issue of sexual dysfunction 💔 in schizophrenia, a side effect that significantly impacts quality of life and treatment adherence 📉. His landmark meta-analysis in JAMA Psychiatry 📘 quantified this burden, influencing clinical guidelines and public discourse. He explores how integrating patient perspectives and improving therapeutic alliances 🤝 can enhance outcomes. His work bridges biological psychiatry and patient-centered care 🩺, emphasizing that innovation is not just drug development, but rethinking care models to reflect human experience 🧠❤️. He champions the inclusion of sexual health in risk-benefit analysis of psychiatric medications 💡. Ultimately, Dr. Korchia’s goal is to evolve psychiatry into a more humane, personalized, and effective field—where each treatment plan respects the unique biology and lived experience of the individual 🌍.

Publications 
  • Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness

    Dialogues in Clinical Neuroscience
    2025-12-31 | Journal article
    CONTRIBUTORS: Théo Korchia; Mélanie Faugère; Vincent Achour; Eloïse Maakaron; Christelle Andrieu-Haller; Guillaume Fond; Christophe Lançon
  • Lifetime sexual violence experienced by women asylum seekers and refugees hosted in high-income countries: Literature review and meta-analysis

    Journal of Forensic and Legal Medicine
    2024-01 | Journal article
    CONTRIBUTORS: Laura Cayreyre; Théo Korchia; Anderson Loundou; Maeva Jego; Didier Théry; Julie Berbis; Gaëtan Gentile; Pascal Auquier; Jérémy Khouani
  • Sexual Dysfunction in Schizophrenia

    JAMA Psychiatry
    2023-11-01 | Journal article
    Part ofISSN: 2168-622X
    CONTRIBUTORS: Théo Korchia; Vincent Achour; Mélanie Faugere; Ali Albeash; Dong Keon Yon; Laurent Boyer; Guillaume Fond
  • Utilizing pharmacogenetics when treating first episode psychosis

    Journal of Psychiatry and Neuroscience
    2023-01-03 | Journal article
    Part of ISSN: 1180-4882
    CONTRIBUTORS: Theo Korchia; Ridha Joober; Raphaelle Richieri; Priyadharshini Sabesan; Lena Palaniyappan